Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

599 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman's age and markers of ovarian reserve.
Di Paola R, Garzon S, Giuliani S, Laganà AS, Noventa M, Parissone F, Zorzi C, Raffaelli R, Ghezzi F, Franchi M, Zaffagnini S. Di Paola R, et al. Among authors: zaffagnini s. Arch Gynecol Obstet. 2018 Nov;298(5):1029-1035. doi: 10.1007/s00404-018-4906-2. Epub 2018 Sep 21. Arch Gynecol Obstet. 2018. PMID: 30242498
Anti-Müllerian hormone and antral follicle count reveal a late impairment of ovarian reserve in patients undergoing low-gonadotoxic regimens for hematological malignancies.
Di Paola R, Costantini C, Tecchio C, Salvagno GL, Montemezzi R, Perandini A, Pizzolo G, Zaffagnini S, Franchi M. Di Paola R, et al. Among authors: zaffagnini s. Oncologist. 2013;18(12):1307-14. doi: 10.1634/theoncologist.2013-0138. Epub 2013 Oct 22. Oncologist. 2013. PMID: 24149138 Free PMC article.
Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study.
Papaleo E, Zaffagnini S, Munaretto M, Vanni VS, Rebonato G, Grisendi V, Di Paola R, La Marca A. Papaleo E, et al. Among authors: zaffagnini s. Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:94-99. doi: 10.1016/j.ejogrb.2016.10.021. Epub 2016 Oct 26. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 27835829
Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
Parissone F, Di Paola R, Balter R, Garzon S, Zaffagnini S, Neri M, Vitale V, Tridello G, Cesaro S. Parissone F, et al. Among authors: zaffagnini s. J Pediatr Endocrinol Metab. 2020 Oct 19;34(1):25-33. doi: 10.1515/jpem-2020-0272. Print 2021 Jan 27. J Pediatr Endocrinol Metab. 2020. PMID: 33068384
A novel de novo partial xq duplication in a girl with short stature, nonverbal learning disability and diminished ovarian reserve - effect of growth hormone treatment and fertility preservation strategies: a case report and up-to-date review.
Parissone F, Pucci M, Meneghelli E, Zuffardi O, Di Paola R, Zaffagnini S, Franchi M, Santangelo E, Cantalupo G, Cavarzere P, Antoniazzi F, Piacentini G, Gaudino R. Parissone F, et al. Among authors: zaffagnini s. Int J Pediatr Endocrinol. 2020;2020:1. doi: 10.1186/s13633-019-0071-z. Epub 2020 Jan 9. Int J Pediatr Endocrinol. 2020. PMID: 31938033 Free PMC article.
Do we trust scientific evidence? A multicentre retrospective analysis of first IVF/ICSI cycles before and after the OPTIMIST trial.
Papaleo E, Revelli A, Costa M, Bertoli M, Zaffagnini S, Tomei F, Manno M, Rebecchi A, Villanacci R, Vanni VS, Cantatore F, Ruffa A, Colia D, Sironi M, Tessari T, Parissone F, Romanello I, Reschini M, Dallagiovanna C, Somigliana E. Papaleo E, et al. Among authors: zaffagnini s. Hum Reprod. 2021 Apr 20;36(5):1367-1375. doi: 10.1093/humrep/deab047. Hum Reprod. 2021. PMID: 33686407
599 results